Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2025-12-24 @ 4:32 PM
NCT ID:
NCT03635866
Eligibility Criteria:
Inclusion Criteria:
* The participant has undergone MRFTB of an MRI lesion at the Department of Urology or at NYU Langone Health within past 12 months and has signed informed consent to participate in the NYU Urology prostate biopsy database.
* The most recent MRFTB of a PIRADS 4 or 5 lesion did not show clinically significant prostate cancer.
Exclusion Criteria:
* The urologist who performed the initial MRFTB does not feel a repeat MRI is indicated.
* Any contraindication to prostate biopsy including untreated urinary tract infection
* Prior allergic reaction to axumin
* Patient refuses MRI
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT03635866
Study Brief:
Protocol Section:
NCT03635866